Correction: Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity

PLoS ONE

Home Correction: Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity

Ryosuke Seki, Akira Ohta, Akira Niwa, Yoshinori Sugimine, Haruna Naito, Tatsutoshi Nakahata, Megumu K. Saito

https://doi.org/10.1371/journal.pone.0249807, Volume: 16, Issue: 4, Pages: 1-1

Article Type: Correction Article History

Publisher: Public Library of Science

Altmetric

Table of Contents

Seki,Ohta,Niwa,Sugimine,Naito,Nakahata,and Saito: Correction: Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity

The affiliation for the third author is incorrect. Akira Niwa is not affiliated with #2 but with #1: Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.

Reference

RSeki, AOhta, ANiwa, YSugimine, HNaito, TNakahata, et al. (2020) Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity. PLoS ONE 15(8): e0237030. 10.1371/journal.pone.0237030